GE Healthcare Technologies Inc. (GEHC) Q3 (USD): Adj. EPS 1.34 (exp. 1.20), Revenue 5.5bln (exp. 5.35bln), Adj. EBIT 913mln (exp. 838.8mln)

GE Healthcare Technologies Inc. (GEHC) Q3 (USD): Adj. EPS 1.34 (exp. 1.20), Revenue 5.5bln (exp. 5.35bln), Adj. EBIT 913mln (exp. 838.8mln)

A clean top-and-bottom-line beat with the margin line also ahead of consensus, the combination that in this sector has tended to be received better than a revenue-driven print, since medical equipment names are valued on conversion of backlog into profitable deliveries rather than on order headline alone. The distinction worth drawing is between a beat driven by consumables and services, which recurs, and one driven by capital equipment shipments, which can reflect timing of installations and pull-forward rather than underlying demand acceleration. Form for this name since its spin-off has been that guidance and margin trajectory on the call matter at least as much as the quarter itself, particularly the imaging and ultrasound order book and any commentary on China demand and hospital capital spending. Worth watching is the margin bridge, free cash flow conversion against the profit beat, and whether the raised or reiterated full-year frame shifts the peer set rather than just this name. As with most equipment beats of this size, the initial move tends to be moderated once the call clarifies sustainability versus phasing.